Heyholder
‹ Activism Filings

SeouLinBioscienceCO.,LTD. Q3 revenue KRW 25.1 billion, profit from the main business KRW 2.1 billion

SeouLinBioscienceCO.,LTD.· Periodic Report

AI summary · Not investment advice

Seorin Bio sold KRW 25.1 billion of goods in Q3 and earned KRW 2.1 billion from its main business, up 166.4% from a year earlier and back in the black from the prior quarter.

Operating profit · 3 months

KRW 2.1 billion

Key facts

Revenue (3 months)
KRW 25.1 billion
Net income (3 months)
KRW 1.4 billion
Period
Q3 (cumulative 2026.01.01 ~ 2026.09.30)
Revenue (prior-year 3 months)
KRW 22.9 billion
Revenue (year to date)
KRW 65.4 billion
Operating profit (prior-year 3 months)
KRW 784.7 million
Operating profit (year to date)
KRW 1.7 billion
Net income (prior-year 3 months)
KRW 755.3 million
Net income (year to date)
KRW 1.9 billion

Commentary

AI commentary · Not investment advice

What happened

Seorin Bio reported its consolidated results for the third quarter of 2026. Sales for the 3 months were KRW 25.09 billion, up 9.7% from KRW 22.87 billion a year earlier. They rose 20.6% from the previous quarter.

In the company's terms

Operating profit (profit from the core business) for the 3 months was KRW 2.09 billion. A year earlier it was KRW 784.7 million, so it rose 166.4%. The company had a loss in the previous quarter and returned to a profit this quarter.

What changes for shareholders

Net income (final profit after taxes and other costs) for the 3 months was KRW 1.38 billion. A year earlier it was KRW 755.3 million, so it rose 82.6%. It rose 303.0% from the previous quarter.

For the year to date (Jan 1 to Sep 30), sales were KRW 65.42 billion. Operating profit was KRW 1.67 billion. Net income was KRW 1.87 billion.

Comments

No comments yet

Comments from shareholders will appear here.